title: Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid.
authors.affiliation: Department of Pediatrics, University of South Florida College of Medicine, Tampa, Florida 33617, USA.
authors.forename: L A
authors.initials: LA
authors.lastname: Smith
authors.forename: J R A
authors.initials: JR
authors.lastname: Ignacio
authors.forename: M P
authors.initials: MP
authors.lastname: Winesett
authors.forename: G C
authors.initials: GC
authors.lastname: Kaiser
authors.forename: A G
authors.initials: AG
authors.lastname: Lacson
authors.forename: E
authors.initials: E
authors.lastname: Gilbert-Barness
authors.forename: R P
authors.initials: RP
authors.lastname: González-Peralta
authors.forename: M J
authors.initials: MJ
authors.lastname: Wilsey
mesh_terms: D019980:Amoxicillin-Potassium Clavulanate Combination / Q000009:adverse effects* / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001649:Bile Duct Diseases / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy; D002648:Child; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014580:Ursodeoxycholic Acid; D019980:Amoxicillin-Potassium Clavulanate Combination